Robert J. Spiegel's Net Worth
$1.56 Million
Who is Robert J. Spiegel?
Robert J. Spiegel has an estimated net worth of $1.56 Million. This is based on reported shares across multiple companies, which include RenovoRx, Inc., Capstone Therapeutics Corp., Sucampo Pharmaceuticals, Inc., GERON CORP, PTC THERAPEUTICS, INC., Edge Therapeutics, Inc., Cyclacel Pharmaceuticals, Inc., Old Ayala, Inc, Athenex, Inc., Ayala Pharmaceuticals, Inc., and Talon Therapeutics, Inc..
SEC CIK
Robert J. Spiegel's CIK is 0001492256
Past Insider Trading and Trends
2018 was Robert J. Spiegel's most active year for acquiring shares with 14 total transactions. Robert J. Spiegel's most active month to acquire stocks was the month of May. 2018 was Robert J. Spiegel's most active year for disposing of shares, totalling 16 transactions. Robert J. Spiegel's most active month to dispose stocks was the month of August. 2014 saw Robert J. Spiegel paying a total of $5,133,155.50 for 199,754 shares, this is the most they've acquired in one year. In 2018 Robert J. Spiegel cashed out on 415,130 shares for a total of $1,522,290.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RenovoRx, Inc. (RNXT) Snapshot price: $1.63
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 40.98K |
—
|
—
| 40.98K |
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Capstone Therapeutics Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sucampo Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -5.13K |
$18.00 | -$92,340.00 |
0
|
Feb 13
| |||
Form 4
| +52.35% | 5.13K |
—
|
—
| 14.93K |
Jun 1
| |||
Form 4
|
∞
| 9.8K |
—
|
—
| 9.8K |
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GERON CORP (GERN) Snapshot price: $1.905
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.59% | -4.38K |
—
|
—
| 168.42K |
Mar 29 - Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
| +2.12% | 3.41K |
—
|
—
| 164.04K |
Dec 29
| |||
Form 4
| +2.16% | 3.39K |
—
|
—
| 160.63K |
Sep 29
| |||
Form 4
| +1.44% | 2.24K |
—
|
—
| 157.24K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
| +2.18% | 3.31K |
—
|
—
| 155K |
Mar 31
| |||
Form 4
| +2.00% | 2.97K |
—
|
—
| 151.69K |
Dec 30
| |||
Form 4
| +2.11% | 3.07K |
—
|
—
| 148.72K |
Sep 30
| |||
Form 4
| +3.29% | 4.64K |
—
|
—
| 145.65K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
| +3.89% | 5.28K |
—
|
—
| 141.01K |
Mar 31
| |||
Form 4
| +4.54% | 5.89K |
—
|
—
| 135.73K |
Dec 31
| |||
Form 4
| +4.21% | 5.25K |
—
|
—
| 129.84K |
Sep 30
| |||
Form 4
| +4.27% | 5.1K |
—
|
—
| 124.59K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
| +3.96% | 4.55K |
—
|
—
| 119.5K |
Mar 31
| |||
Form 4
| +4.09% | 4.52K |
—
|
—
| 114.95K |
Dec 31
| |||
Form 4
| +3.89% | 4.13K |
—
|
—
| 110.43K |
Sep 30
| |||
Form 4
| +3.20% | 3.3K |
—
|
—
| 106.3K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
| +6.23% | 6.04K |
—
|
—
| 103K |
Mar 31
| |||
Form 4
| +5.76% | 5.28K |
—
|
—
| 96.96K |
Dec 31
| |||
Form 4
| +6.26% | 5.4K |
—
|
—
| 91.68K |
Sep 30
| |||
Form 4
| +6.28% | 5.1K |
—
|
—
| 86.27K |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +5.63% | 4.33K |
—
|
—
| 81.18K |
Mar 29
| |||
Form 4
| +10.32% | 7.19K |
—
|
—
| 76.85K |
Dec 31
| |||
Form 4
| +6.23% | 4.08K |
—
|
—
| 69.66K |
Sep 28
| |||
Form 4
|
—
|
0
|
$4.90 | -$682,200.00 | 65.58K |
Scheduled
|
Sep 13
| ||
Form 4
| +3.30% | 2.1K |
—
|
—
| 65.58K |
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
| +2.74% | 1.69K |
—
|
—
| 63.48K |
Mar 29
| |||
Form 4
| +6.91% | 3.99K |
—
|
—
| 61.79K |
Dec 29
| |||
Form 4
| +6.05% | 3.3K |
—
|
—
| 57.8K |
Sep 29
| |||
Form 4
| +5.00% | 2.6K |
—
|
—
| 54.5K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
| +6.50% | 3.17K |
—
|
—
| 51.91K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +4.75% | 2.21K |
—
|
—
| 48.74K |
Dec 31
| |||
Form 4
| +4.44% | 1.98K |
—
|
—
| 46.53K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| +18.26% | 6.88K |
—
|
—
| 44.55K |
Mar 31
| |||
Form 4
| +8.76% | 3.03K |
—
|
—
| 37.67K |
Dec 31
| |||
Form 4
| +14.14% | 4.29K |
—
|
—
| 34.64K |
Sep 30
| |||
Form 4
| -59.72% | -45.00K |
—
|
—
| 30.35K |
Jul 9
| |||
Form 4
| -59.72% | -45.00K |
—
|
—
| 30.35K |
Jul 9
| |||
Form 4
| +6.79% | 4.79K |
—
|
—
| 75.35K |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +10.52% | 6.72K |
—
|
—
| 70.56K |
Mar 29
| |||
Form 4
| +4.24% | 2.6K |
—
|
—
| 63.84K |
Dec 31
| |||
Form 4
| +7.37% | 4.2K |
—
|
—
| 61.24K |
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| +9.61% | 5K |
—
|
—
| 57.04K |
May 20
| |||
Form 4
| +15.64% | 7.04K |
—
|
—
| 52.04K |
May 11
| |||
Form 4
|
∞
| 45K |
—
|
—
| 45K |
Jul 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PTC THERAPEUTICS, INC. (PTCT) Snapshot price: $25.29
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| -24.13% | -1.03K |
$75.10 | -$77,354.70 | 3.24K |
Scheduled
|
Mar 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +38.47% | 1.19K |
$31.75 | $37,655.50 | 4.27K |
Scheduled
|
Mar 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||